In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc

M Jones, A H Peden, C V Prowse, A Gröner, J C Manson, M L Turner, J W Ironside, I R MacGregor, M W Head

Research output: Contribution to journalArticlepeer-review


Variant Creutzfeldt-Jakob disease (vCJD) poses a serious risk of secondary transmission and the need to detect infectivity in asymptomatic individuals is therefore of major importance. Following infection, it is assumed that minute amounts of disease-associated prion protein (PrP(Sc)) replicate by conversion of the host cellular prion protein (PrP(C)). Therefore, methods of rapidly reproducing this conversion process in vitro would be valuable tools in the development of such tests. We show that one such technique, protein misfolding cyclic amplification (PMCA), can amplify vCJD PrP(Sc) from human brain tissue, and that the degree of amplification is dependent upon the substrate PRNP codon 129 polymorphism. Both human platelets and transgenic mouse brain are shown to be suitable alternative substrate sources, and amplified PrP(Sc) can be detected using a conformation-dependent immunoassay (CDI), allowing the detection of putative proteinase K sensitive forms of PrP(Sc).
Original languageEnglish
Pages (from-to)21-6
Number of pages6
JournalThe Journal of Pathology
Issue number1
Publication statusPublished - 2007


Dive into the research topics of 'In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc'. Together they form a unique fingerprint.

Cite this